Protalix BioTherapeutics, Inc. (PLX) financial statements (2021 and earlier)

Company profile

Business Address 2 UNIVERSITY PLAZA
HACKENSACK, NJ 07601
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments18183851637655
Cash and cash equivalents18183851637655
Restricted cash and investments      0
Receivables25521 2
Inventory, net of allowances, customer advances and progress billings13898567
Inventory13898567
Prepaid expense      0
Disposal group, including discontinued operation    02 
Other current assets2222222
Other undisclosed current assets20     (1)
Total current assets:56325363728666
Noncurrent Assets
Operating lease, right-of-use asset66
Property, plant and equipment556891011
Deferred costs      0
Defined benefit plan, assets for plan benefits222
Other undisclosed noncurrent assets2222   
Total noncurrent assets:1213810101113
TOTAL ASSETS:68456172829778
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities14121097627
Accounts payable14121097619
Accrued liabilities      5
Employee-related liabilities      1
Interest and dividends payable      1
Deferred revenue516
Debt605 654  
Disposal group, including discontinued operation     2 
Deferred revenue and credits 117
Contract with customer, liability10
Other undisclosed current liabilities765844(7)
Total current liabilities:86402523661126
Noncurrent Liabilities
Long-term debt and lease obligation455484624721
Long-term debt, excluding current maturities 51484624721
Operating lease, liability45
Liabilities, other than long-term debt42041342339
Deferred revenue and credits27 137
Deferred revenue217
Contract with customer, liability33
Liability, pension and other postretirement and postemployment benefits2323222
Other liabilities0155   
Other undisclosed noncurrent liabilities      67
Total noncurrent liabilities:87689812675108
Total liabilities:951161141049286134
Stockholders' equity
Stockholders' equity attributable to parent(27)(70)(53)(31)(10)11(56)
Common stock0000000
Additional paid in capital320270270266203194186
Accumulated deficit(347)(341)(323)(298)(213)(183)(241)
Total stockholders' equity:(27)(70)(53)(31)(10)11(56)
TOTAL LIABILITIES AND EQUITY:68456172829778

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues6355 199414
Revenue, net   14
Cost of revenue(11)(11)(9)(15)(8)(1)(9)
Cost of goods and services sold(0)(1)(1) (0)(1)(2)
Other undisclosed gross profit      2
Gross profit:5244(9)4146
Operating expenses(49)(55)(46)(44)(40)(32)(39)
Other undisclosed operating income 0363658
Operating income (loss):3(11)(19)(36)(33)(24)(25)
Nonoperating income (expense)(9)(8)(7)(49)4(4)(5)
Foreign currency transaction loss, before tax      (1)
Other nonoperating expense(9)(8)(7)(10)(10)(4)(5)
Interest and debt expense(3)(3)(3)(2)(1)(4)(4)
Loss from continuing operations:(10)(21)(29)(88)(30)(31)(33)
Income (loss) from discontinued operations    (0)45 
Net income (loss):(10)(21)(29)(88)(30)15(33)
Other undisclosed net income attributable to parent33321434
Net income (loss) available to common stockholders, diluted:(7)(18)(26)(85)(29)58(30)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(10)(21)(29)(88)(30)15(33)
Comprehensive income (loss), net of tax, attributable to parent:(10)(21)(29)(88)(30)15(33)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: